Phoenix Wealth Advisors Sells 16,204 Shares of ALPS Medical Breakthroughs ETF $SBIO

Phoenix Wealth Advisors lowered its stake in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 62.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,902 shares of the company’s stock after selling 16,204 shares during the quarter. Phoenix Wealth Advisors owned about 0.50% of ALPS Medical Breakthroughs ETF worth $385,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in SBIO. Sterling Investment Advisors Ltd. purchased a new stake in shares of ALPS Medical Breakthroughs ETF during the third quarter valued at about $315,000. Moran Wealth Management LLC raised its stake in shares of ALPS Medical Breakthroughs ETF by 72.2% during the 3rd quarter. Moran Wealth Management LLC now owns 17,187 shares of the company’s stock worth $668,000 after acquiring an additional 7,206 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in ALPS Medical Breakthroughs ETF during the second quarter valued at approximately $82,000. Ally Invest Advisors Inc. acquired a new stake in ALPS Medical Breakthroughs ETF in the second quarter valued at approximately $200,000. Finally, Strategic Financial Services Inc. grew its holdings in ALPS Medical Breakthroughs ETF by 97.8% in the second quarter. Strategic Financial Services Inc. now owns 38,032 shares of the company’s stock worth $1,144,000 after purchasing an additional 18,807 shares during the last quarter.

ALPS Medical Breakthroughs ETF Stock Down 0.3%

Shares of SBIO stock opened at $51.07 on Friday. ALPS Medical Breakthroughs ETF has a 12-month low of $22.33 and a 12-month high of $52.90. The business’s fifty day simple moving average is $49.72 and its 200-day simple moving average is $41.24.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.